NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free SGRY Stock Alerts $25.38 +1.34 (+5.57%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$24.04▼$25.4450-Day Range$23.42▼$34.7052-Week Range$22.05▼$45.79Volume1.11 million shsAverage Volume901,231 shsMarket Capitalization$3.21 billionP/E RatioN/ADividend YieldN/APrice Target$43.63 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Surgery Partners alerts: Email Address Surgery Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside71.9% Upside$43.63 Price TargetShort InterestBearish11.33% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 3 Articles This WeekInsider TradingSelling Shares$608,352 Sold Last QuarterProj. Earnings Growth35.90%From $0.78 to $1.06 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.32 out of 5 starsMedical Sector720th out of 909 stocksGeneral Medical & Surgical Hospitals Industry5th out of 5 stocks 3.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSurgery Partners has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.33% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in Surgery Partners has recently increased by 2.86%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 3 news articles for Surgery Partners this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $608,352.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of Surgery Partners is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 35.90% in the coming year, from $0.78 to $1.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -253.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -253.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 2.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Surgery Partners Stock (NASDAQ:SGRY)Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Read More SGRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SGRY Stock News HeadlinesApril 18, 2024 | globenewswire.comSurgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call DetailsApril 17, 2024 | nasdaq.comSurgery Partners Enters Oversold Territory (SGRY)April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 14, 2024 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Trading 2.6% Higher March 29, 2024 | markets.businessinsider.comSurgery Partners: A Buy Rating Amidst Underperformance and Growth PotentialMarch 26, 2024 | seekingalpha.comSurgery Partners to offer $600M senior unsecured notesMarch 26, 2024 | globenewswire.comSurgery Partners, Inc. Announces Pricing of New Senior Notes OfferingMarch 26, 2024 | globenewswire.comSurgery Partners, Inc. Announces New Senior Notes OfferingApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 25, 2024 | finance.yahoo.comInvestors Met With Slowing Returns on Capital At Surgery Partners (NASDAQ:SGRY)March 7, 2024 | finance.yahoo.comInsider Sell: CFO David Doherty Sells 3,426 Shares of Surgery Partners Inc (SGRY)March 6, 2024 | realmoney.thestreet.comSurgery Partners initiated with neutral view at BarclaysMarch 1, 2024 | finance.yahoo.comSurgery Partners, Inc. (NASDAQ:SGRY) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | ca.finance.yahoo.comSGRY Mar 2024 30.000 putMarch 1, 2024 | markets.businessinsider.comSurgery Partners: Maintaining Buy Rating with Slight EBITDA Adjustment and Price Target IncreaseFebruary 28, 2024 | seekingalpha.comSurgery Partners, Inc. (SGRY) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | markets.businessinsider.comSurgery Partners: Strong Q4 Performance and Growth Outlook Secure Buy RatingFebruary 27, 2024 | markets.businessinsider.comSurgery Partners’ Expansion and Positive Earnings Outlook Prompt ‘Buy’ RatingFebruary 27, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights Microsoft, Amazon.com, Surgery Partners, Nvidia and Occidental PetroleumFebruary 27, 2024 | finance.yahoo.comCompany News for Feb 27, 2024February 27, 2024 | finance.yahoo.comQ4 2023 Surgery Partners Inc Earnings CallFebruary 26, 2024 | washingtonpost.comSurgery Partners: Q4 Earnings SnapshotFebruary 26, 2024 | finance.yahoo.comSurgery Partners Inc (SGRY) Reports Solid Revenue and EBITDA Growth in Full Year 2023 ResultsFebruary 26, 2024 | globenewswire.comSurgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 GuidanceFebruary 24, 2024 | finance.yahoo.comSGRY Apr 2024 50.000 callFebruary 21, 2024 | finance.yahoo.comGear Up for Surgery Partners (SGRY) Q4 Earnings: Wall Street Estimates for Key MetricsFebruary 20, 2024 | wfft.comParkview Health and Surgery Partners announce agreement to grow ambulatory surgical center ventures across IndianaSee More Headlines Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2024Today4/23/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General medical & surgical hospitals Sub-IndustryN/A Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees13,500Year FoundedN/APrice Target and Rating Average Stock Price Target$43.63 High Stock Price Target$50.00 Low Stock Price Target$35.00 Potential Upside/Downside+72.3%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E Ratio32.46 P/E Growth2.18Net Income$-11,900,000.00 Net Margins-0.43% Pretax Margin4.92% Return on Equity3.65% Return on Assets1.62% Debt Debt-to-Equity Ratio0.89 Current Ratio1.71 Quick Ratio1.57 Sales & Book Value Annual Sales$2.74 billion Price / Sales1.17 Cash Flow$1.91 per share Price / Cash Flow13.27 Book Value$23.99 per share Price / Book1.06Miscellaneous Outstanding Shares126,610,000Free Float123,315,000Market Cap$3.21 billion OptionableOptionable Beta2.71 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Wayne Scott DeVeydt (Age 54)Executive Chairman Comp: $250kMr. J. Eric Evans (Age 47)CEO & Director Comp: $1.45MMr. David T. Doherty (Age 52)Executive VP & CFO Comp: $1.03MMs. Jennifer B. Baldock (Age 53)Executive VP and Chief Administrative & Development Officer Comp: $1.05MMr. Bradley R. Owens (Age 54)President of National Group Comp: $684.02kMr. Harrison R. Bane (Age 37)President of American Group Comp: $428.77kMr. Neil C. Zieselman (Age 48)Senior Vice President of Corporate Finance & Controller Mr. Varun GadhokSenior VP & Chief Information OfficerMs. Roxanne WomackSenior VP & Chief Compliance OfficerMs. Danielle Burkhalter (Age 39)Chief Human Resources Officer More ExecutivesKey CompetitorsCommunity Health SystemsNYSE:CYHTenet HealthcareNYSE:THCUniversal Health ServicesNYSE:UHSXenon PharmaceuticalsNASDAQ:XENEAmicus TherapeuticsNASDAQ:FOLDView All CompetitorsInsiders & InstitutionsWesbanco Bank Inc.Bought 25,663 shares on 4/23/2024Ownership: 0.020%Cannon Global Investment Management LLCBought 20,600 shares on 4/17/2024Ownership: 0.016%Los Angeles Capital Management LLCBought 3,720 shares on 4/5/2024Ownership: 0.017%Jason Eric EvansSold 4,840 sharesTotal: $143,796.40 ($29.71/share)Vanguard Group Inc.Bought 698,845 shares on 3/11/2024Ownership: 5.859%View All Insider TransactionsView All Institutional Transactions SGRY Stock Analysis - Frequently Asked Questions Should I buy or sell Surgery Partners stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SGRY shares. View SGRY analyst ratings or view top-rated stocks. What is Surgery Partners' stock price target for 2024? 8 Wall Street research analysts have issued 12 month price objectives for Surgery Partners' stock. Their SGRY share price targets range from $35.00 to $50.00. On average, they anticipate the company's stock price to reach $43.63 in the next year. This suggests a possible upside of 71.9% from the stock's current price. View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts. How have SGRY shares performed in 2024? Surgery Partners' stock was trading at $31.99 on January 1st, 2024. Since then, SGRY stock has decreased by 20.7% and is now trading at $25.38. View the best growth stocks for 2024 here. When is Surgery Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our SGRY earnings forecast. How can I listen to Surgery Partners' earnings call? Surgery Partners will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13746011". How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) released its quarterly earnings data on Monday, February, 26th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.07. The firm earned $735.40 million during the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive trailing twelve-month return on equity of 3.65%. The firm's revenue was up 4.0% on a year-over-year basis. During the same period last year, the firm posted $0.22 earnings per share. What ETFs hold Surgery Partners' stock? ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), BlackRock Future Innovators ETF (BFTR) and Harbor Corporate Culture Small Cap ETF (HAPS).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Surgery Partners issued on next quarter's earnings? Surgery Partners issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.0 billion-, compared to the consensus revenue estimate of $3.0 billion. What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR). Who are Surgery Partners' major shareholders? Surgery Partners' stock is owned by many different institutional and retail investors. Top institutional shareholders include Wesbanco Bank Inc. (0.02%), Los Angeles Capital Management LLC (0.02%) and Cannon Global Investment Management LLC (0.02%). Insiders that own company stock include Andrew T Kaplan, Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SGRY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.